AI Science Tracker

Weizmann Institute of Science

1 discovery from 2026

Discoveries

AI-designed bacterial anti-defense proteins enable phage infection and plasmid retention

RFdiffusion-based de novo binder design and experimental screening produced synthetic proteins that inhibited three bacterial defense systems: Thoeris and Avs1 in Bacillus subtilis assays, and DdmDE in Vibrio cholerae. Five designed proteins inhibited Thoeris and nine inhibited Avs1 in the reported screens. An engineered SBSphiJ phage carrying both anti-Thoeris and anti-Avs1 proteins replicated in B. subtilis cells expressing both defenses. In native V. cholerae O1 El Tor, two of four tested DdmDE binders improved plasmid resistance to clearance.

Technology: RFdiffusion de novo binder design, ProteinMPNN sequence design and AlphaFold2/3 structure-guided candidate scoring

Family AlphaFold: profile · models page

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: RFdiffusion-based de novo binder design and experimental screening produced synthetic proteins that inhibited three bacterial defense systems: Thoeris and Avs1 in Bacillus subtilis assays, and DdmDE in Vibrio cholerae.
  • Still unknown: These are laboratory proof-of-concept results in three bacterial defense systems and specific strains; they do not demonstrate therapeutic phage efficacy in animals or humans. Binder success was low relative to the computationally designed candidate sets, and the authors note that a verified binder may not work against homologous defense proteins. The native V. cholerae result was tested for plasmid retention, not general transformation across clinical isolates. The earlier bioRxiv version is the same study and is not a separate record.
  • AI role: RFdiffusion generated candidate binder backbones for selected target sites in the Thoeris, Avs1 and DdmDE defense proteins; ProteinMPNN designed sequences and AlphaFold-based co-folding/scoring prioritized candidates for experiments. The selected synthetic binders were tested for defense inhibition, direct interactions and ability to restore phage infection or plasmid retention. The measured anti-defense functions and engineered-phage outcomes are the paper-specific results enabled by AI-guided protein design.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13402655/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.